Ellen Bateman is an executive leader in the healthcare bio-pharma industry. In her current role, she spearheads strategy development, technology enablement and business to business solutions for health systems, federal agencies and supply chain partners on a national scale.

With a profound commitment to prevention and population health, Bateman has dedicated her career to patient-centric initiatives, leveraging innovative strategies to drive impactful outcomes. In her previous leadership roles at Myriad Genetics and Exact Sciences, she led national commercial teams in cancer prevention and detection, emphasizing technology and EHR integration.

Bateman's extensive experience includes a 20-year tenure at Merck's vaccines division, where she played a pivotal role in advancing immunization efforts. She holds an MBA from the Kellogg School of Management at Northwestern University and a BS from Winona State University.